Traws Pharma Inc (TRAW)

04:26 AM

Millennium Management LLC Buys New Holdings in Traws Pharma, Inc. (NASDAQ:TRAW) - Defense World

04:26 AM

Jun 12, 2025

Traws Pharma Announces Promising Clinical Data for Rigosertib in Rare Cancer - MSN

Jun 12, 2025

Jun 10, 2025

Traws Pharma (NASDAQ:TRAW) Trading 0.6% Higher – Here’s What Happened - Defense World

Jun 10, 2025

Jun 07, 2025

Traws Pharma Highlights Q1 2025 Financial Progress and Antiviral Developments - MSN

Jun 07, 2025

Jun 03, 2025

Traws Pharma Inc. Stock Skyrockets Over 40%, Then Pares Gains in Volatile Trading - Daily Chhattisgarh News

Jun 03, 2025

Jun 03, 2025

Traws Pharma Stock (TRAW) Surges 55% on Positive Cancer Data - TipRanks

Jun 03, 2025

Jun 03, 2025

Traws Pharma (TRAW) Releases Promising Clinical Trial Results fo - GuruFocus

Jun 03, 2025

Jun 03, 2025

Traws Pharma Publishes Promising Phase 2 Study Results - TipRanks

Jun 03, 2025

Jun 03, 2025

Traws Pharma Announces Publication of Compelling Efficacy - GlobeNewswire

Jun 03, 2025

Jun 03, 2025

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib - GlobeNewswire Inc.

Jun 03, 2025

May 31, 2025

Traws Pharma Receives FDA Feedback on Flu Drug Development - MSN

May 31, 2025

May 28, 2025

Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir - GlobeNewswire

May 28, 2025

May 27, 2025

Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness - marketscreener.com

May 27, 2025

May 27, 2025

Traws Pharma advances flu drug development with FDA feedback - Investing.com India

May 27, 2025

May 27, 2025

Traws Pharma Announces Receipt Of FDA Guidance On Tivoxavir Marboxil, Plans For Pursuing Stockpiling For Pandemic Preparedness - marketscreener.com

May 27, 2025

May 27, 2025

Traws Pharma Receives FDA Guidance on Flu Treatment - TipRanks

May 27, 2025

May 27, 2025

Traws Pharma (TRAW) Gains FDA Insights on Flu Treatment Pathway | TRAW Stock News - GuruFocus

May 27, 2025

May 27, 2025

Traws Pharma advances flu drug development with FDA feedback By Investing.com - Investing.com Nigeria

May 27, 2025

May 27, 2025

FDA Advances Critical Bird Flu Drug Development as Ex-CDC Chief Warns of 50% Death Rate Risk - Stock Titan

May 27, 2025

May 19, 2025

Traws Pharma Unveils New Strategic Antiviral Focus - TipRanks

May 19, 2025

May 16, 2025

Traws Pharma’s Q1 2025 Results Highlight Progress and Profit - TipRanks

May 16, 2025

May 15, 2025

Traws Pharma Reports First Quarter 2025 Results And Business Highlights - marketscreener.com

May 15, 2025

May 15, 2025

Traws Pharma Reports Q1 2025 Financial Results - TipRanks

May 15, 2025

May 15, 2025

Traws Pharma Reports First Quarter 2025 Results and Business Highlights - GlobeNewswire

May 15, 2025

May 15, 2025

Traws Pharma Earnings Surge to $21.5M as Former CDC Director Backs Novel Flu and COVID Drug Pipeline - Stock Titan

May 15, 2025

May 08, 2025

Renaissance Technologies LLC Takes $89,000 Position in Traws Pharma, Inc. (NASDAQ:TRAW) - Defense World

May 08, 2025

May 04, 2025

Geode Capital Management LLC Makes New $185,000 Investment in Traws Pharma, Inc. (NASDAQ:TRAW) - Defense World

May 04, 2025

Apr 24, 2025

TRAWTraws Pharma Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 23, 2025

TRAW stock touches 52-week low at $1.51 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

TRAW stock touches 52-week low at $1.51 amid sharp annual decline - Investing.com India

Apr 23, 2025

Apr 19, 2025

Traws Pharma Appoints New Chairman Amid Leadership Changes - MSN

Apr 19, 2025

Apr 18, 2025

Traws Pharma appoints new interim CEO with compensation details By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 18, 2025

Traws Pharma appoints new interim CEO with compensation details - Investing.com Australia

Apr 18, 2025

Apr 08, 2025

Traws Pharma announces $50 million stock offering potential - Investing.com Australia

Apr 08, 2025

Apr 07, 2025

Traws Pharma announces $50 million stock offering potential By Investing.com - Investing.com Canada

Apr 07, 2025

Apr 07, 2025

Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment - MSN

Apr 07, 2025

Apr 05, 2025

Traws Pharma Reports 2024 Financial Results and Advances Bird Flu and COVID Programs - MSN

Apr 05, 2025

Apr 02, 2025

TRAW stock touches 52-week low at $2.01 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 02, 2025

TRAW stock touches 52-week low at $2.01 amid sharp annual decline - Investing.com India

Apr 02, 2025

Apr 02, 2025

Traws Pharma CEO Werner Cautreels to retire - MSN

Apr 02, 2025

Apr 01, 2025

Traws Pharma Reports 2024 Results and Strategic Progress - TipRanks

Apr 01, 2025

Mar 31, 2025

Traws Pharma Showcases Promising COVID-19 Drug at ICAR Conference - MSN

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost By Investing.com - Investing.com South Africa

Mar 31, 2025